Cargando…
Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer
BACKGROUND: Pancreatic cancer is a lethal disease in part because of its potential for aggressive invasion and metastasis. Lipoxin A4 (LXA4) is one of the metabolites that is derived from arachidonic acid and that is catalyzed by 15-lipoxygenase (15-LOX), and it has recently been reported to exhibit...
Autores principales: | Zong, Liang, Chen, Ke, Jiang, Zhengdong, Chen, Xin, Sun, Liankang, Ma, Jiguang, Zhou, Cancan, Xu, Qinhong, Duan, Wanxing, Han, Liang, Lei, Jianjun, Li, Xuqi, Ma, Qingyong, Wang, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725800/ https://www.ncbi.nlm.nih.gov/pubmed/29228980 http://dx.doi.org/10.1186/s13046-017-0655-5 |
Ejemplares similares
-
Lipoxin A(4) Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer
por: Zong, Liang, et al.
Publicado: (2016) -
Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions
por: Jiang, Zhengdong, et al.
Publicado: (2018) -
Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1
por: Zhou, Cancan, et al.
Publicado: (2018) -
Resveratrol Ameliorates the Malignant Progression of Pancreatic Cancer by Inhibiting Hypoxia-induced Pancreatic Stellate Cell Activation
por: Xiao, Ying, et al.
Publicado: (2020) -
YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine
por: Jiang, Zhengdong, et al.
Publicado: (2016)